Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025 Jun 05; 392(21):2089-2099.
View in:
PubMed
subject areas
Adult
Aged
Biopsy
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Glucagon-Like Peptide 1
Humans
Injections, Subcutaneous
Liver
Liver Cirrhosis
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Severity of Illness Index
Treatment Outcome
authors with profiles
Mary Rinella